Mostrando 361 - 380 Resultados de 3,294 Para Buscar '"gout"', tiempo de consulta: 0.21s Limitar resultados
  1. 361
    por Singh, Jasvinder A.
    Publicado 2021
    “…OBJECTIVE: Medication adherence in gout is suboptimal, and the lack of effective interventions to address it presents a huge challenge. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 362
    “…BACKGROUND: This study aimed to explore the clinical characteristics of perioperative acute gout attacks in patients with varying uric acid levels undergoing orthopedic surgery, identify the risk factors for gout recurrence within the first postoperative year, and provide a disease prevention and diagnostic reference. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 363
    “…BACKGROUND AND OBJECTIVES: Characterized by sudden onset of severe joint pain, swelling, redness, and tenderness to touch, gout ‘flare ups’ have a substantial impact on quality of life (QoL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 364
  5. 365
    “…Patient: Male, 46-year-old Final Diagnosis: Chronic tophaceous gout with disseminated cutaneous tophi Symptoms: Joint pain Medication: — Clinical Procedure: — Specialty: Rheumatology OBJECTIVE: Rare disease BACKGROUND: Gout is a metabolic disease characterized by deposition of monosodium urate (MSU) crystals called tophi. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 366
  7. 367
    “…OBJECTIVES: To explore the frequency and predictors of flares over 2 years during a treat-to-target strategy with urate-lowering therapy (ULT) in patients with gout. METHODS: In the treat-to-target, tight control NOR-Gout study patients started ULT with escalating doses of allopurinol. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 368
  9. 369
    “…(1) Background: A tophus is a clinical manifestation of advanced gout, and in some patients could lead to joint deformities, fractures, and even serious complications in unusual sites. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 370
    por Liu, Ya-ru, Wang, Jie-quan, Li, Jun
    Publicado 2023
    “…Gout arthritis (GA) is a common and curable type of inflammatory arthritis that has been attributed to a combination of genetic, environmental and metabolic factors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 371
    “…Studies of neurodegenerative disease risk in gout are contradictory. Relationships with neuroimaging markers of brain structure, which may offer insights, are uncertain. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 372
    por Ahn, Joong Kyong
    Publicado 2023
    “…Gout is the most common form of inflammatory arthritis that affects mainly middle-aged men, and there is clear evidence of an association between hyperuricemia and the risk for gout. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 373
  14. 374
    “…OBJECTIVE: Preliminary remission criteria for gout have been developed. However, the patient experience of gout remission has not been described. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 375
    “…BACKGROUND: The Gout Impact Scale (GIS), part of the Gout Assessment Questionnaire 2.0, measures gout-specific health-related quality of life (HRQOL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 376
    “…BACKGROUND: Rarely, chronic tophaceous gout can result in lumbar spinal stenosis and neural compression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 377
    “…Gout is a common inflammatory arthritis that has been increasing in both prevalence and incidence. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 378
  19. 379
    por Hu, Miao, Tomlinson, Brian
    Publicado 2008
    “…Febuxostat has been granted marketing authorization by the European Commission in early 2008 for the treatment of chronic hyperuricemia and gout. Febuxostat is the first major treatment alternative for gout in more than 40 years and is a promising alternative to allopurinol, although continued long-term surveillance on safety and efficacy is required.…”
    Enlace del recurso
    Enlace del recurso
    Texto
  20. 380
    por Gaffo, Angelo L, Saag, Kenneth G
    Publicado 2010
    “…INTRODUCTION: Gout is a common and disabling cause of arthritis in middle-aged and elderly populations, with its main predisposing factor being hyperuricemia (serum urate > 6.8 mg/dL). …”
    Enlace del recurso
    Enlace del recurso
    Texto
Herramientas de búsqueda: RSS